Ventyx Biosciences, Inc.
VTYX
$1.20
-$0.06-4.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 16.73% | -10.33% | 17.17% | 17.50% | 13.46% |
| Total Depreciation and Amortization | 1.94% | -2.22% | -22.55% | 1.24% | 52.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.84% | -6.08% | -32.93% | 14.04% | -32.67% |
| Change in Net Operating Assets | 180.21% | -182.54% | 129.15% | -50.88% | -170.01% |
| Cash from Operations | 34.44% | -44.51% | 48.48% | 7.80% | -49.02% |
| Capital Expenditure | -- | 100.00% | 65.71% | 17.06% | -339.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -137.58% | 138.76% | -279.92% | -9.49% | 19.00% |
| Cash from Investing | -137.60% | 138.73% | -280.82% | -9.45% | 18.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,750.00% | -- | -- | 22,062.21% | -74.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 293.59% |
| Cash from Financing | -100.09% | 3,064.90% | -100.94% | 16,341.71% | -64.00% |
| Foreign Exchange rate Adjustments | -221.35% | 2,233.33% | -80.00% | 94.19% | -637.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -265.57% | 120.64% | -211.80% | 1,895.25% | -185.74% |